Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ENFLONSIA safely and effectively. See full prescribing information for ENFLONSIA. ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use Initial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-prescription
ENFLONSIA is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.
- generic_name
- clesrovimab
- product_names
- CLESROVIMAB
- ndc
- 0006-5073, 0006-5073-99, 0006-5073-01, 0006-5073-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en